Latest / The BioHub - by Avetix
Episode 181 - Pete Smith - Co-Founder, CEO & President of Remix Therapeutics
Today on the podcast, we’re joined by Peter Smith, co-founder and CEO of — a company pioneering a new frontier in RNA-processing therapeutics.
Peter has spent more than two decades at the forefront of oncology and drug discovery, with leadership roles spanning Takeda, Millennium Pharmaceuticals, and H3 Biomedicine before launching Remix to tackle diseases through precision RNA modulation.
Remix is working to transform patient's lives through modulation of RNA processing and addressing drug targets in diseases of high unmet medical need. They're a clinical-stage biotechnology company…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.